INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$192
1 sh
Feb 2, 2026Feb 4, 2026
Page 1380 of 1814
← PrevNext →
traded Feb 2, 2026
+2d
SEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,844 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
FA
Fang AndyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
10.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
FA
Fang AndyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
10.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Option exercise · 10b5-1 plan
M—
2,000 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
45.4K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1,626
156 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
45.4K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Derivative conversion · 10b5-1 plan
C—
2,000 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M$2,800
5,000 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

41
MJ
Malm JoshuaCFO
FEAM5E Advanced Materials, Inc.
Open-market purchase
BUY$7,500
3,750 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

37
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Open-market sale
SELL$190K
926 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

36
WR
Wilcox Jon RDirector
MCHBMechanics Bancorp
Grant or award
A—
2,554 sh
Sep 2, 2025Feb 3, 2026
traded Sep 2, 2025
+154dSEC Form 4

Evidence

33
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$165K
1,662 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

33
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$117K
1,166 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

30
LR
Lord RachelSenior Managing Director
BLKBlackRock, Inc.
Tax withholding
F$3.12M
2,787 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

30
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$49K
492 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

30
MT
McGrath Austin ThomasVP, CAO, and Controller
ALLYAlly Financial Inc.
Grant or award
A$1.18M
27.9K sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

30
CS
Cohen StephenSenior Managing Director
BLKBlackRock, Inc.
Tax withholding
F$2.39M
2,135 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

30
MJ
Meade Christopher J.General Counsel and CLO
BLKBlackRock, Inc.
Tax withholding
F$3.89M
3,475 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

29
LE
Lee David EricVICE CHAIR, WINTRUST FINANCIAL
WTFCWINTRUST FINANCIAL CORP
Open-market sale
SELL$82K
558 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

27
LN
Lentz Randy NSee Remarks
OKEONEOK INC /NEW/
Option exercise
M$519K
6,557 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

26
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Tax withholding
F$4.20M
3,756 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

26
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$8,999
93 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

25
ME
Moritz Robert Edward Jr.Director
NTRSNORTHERN TRUST CORP
Open-market purchase
BUY$37K
245 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

25
FL
Fink LaurenceDirector, Chairman and CEO
BLKBlackRock, Inc.
Tax withholding
F$16.11M
14.4K sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

25
KR
Kapito RobertDirector, President
BLKBlackRock, Inc.
Tax withholding
F$12.10M
10.8K sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

24
KP
Koch Darryl P.EVP & CITSO, Individual
CCNECNB FINANCIAL CORP/PA
Grant or award
A$52K
1,895 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

24
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Tax withholding
F$178K
894 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

24
WR
Wilcox Jon RDirector
MCHBMechanics Bancorp
Grant or award
A—
13.2K sh
Sep 2, 2025Feb 3, 2026
traded Sep 2, 2025
+154dSEC Form 4

Evidence

24
ZF
Zycinski FrankRegional President - EMEA
PLXSPLEXUS CORP
Tax withholding
F$135K
677 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

24
MR
Mink RobinEVP/Chief TM Officer
CCNECNB FINANCIAL CORP/PA
Grant or award
A$70K
2,527 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

23
LA
Landucci AmyChief Information Officer
SOLVSolventum Corp
Tax withholding
F$805K
10.5K sh
Feb 1, 2026Feb 3, 2026
traded Feb 1, 2026
+2dSEC Form 4

Evidence

23
SJ
Swain JunkoSVP, Chief Accounting Officer
WKWORKIVA INC
Grant or award
A$525K
6,859 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

23
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Grant or award
A$788K
18.6K sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

23
RN
Richard Stephanie NChief Risk Officer
ALLYAlly Financial Inc.
Grant or award
A$803K
19.0K sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

23
HC
Heller CarolineSenior Managing Director
BLKBlackRock, Inc.
Tax withholding
F$828K
740 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

22
HC
Hall William Cadik Jr.President - Corporate Finance
ALLYAlly Financial Inc.
Grant or award
A$1.16M
27.5K sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence